Network origin in Jim Wang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jim Wang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BECTON, DICKINSON AND COMPANY | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| UNILIFE CORP | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Doctorate Degree Undergraduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Corporate Officer/Principal | |
| CLEARSIDE BIOMEDICAL, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin | |
| Euro Ventures, Inc. | Founder | ||
| PLIANT THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Chief Operating Officer | |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
| NKARTA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Clinvec Solutions LLC | Miscellaneous | Corporate Officer/Principal | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Pharmaceuticals: Major | Director/Board Member | |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Pharmaceuticals: Major | Director/Board Member | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member | |
Jengu Therapeutics, Inc.
 Jengu Therapeutics, Inc. BiotechnologyHealth Technology Jengu Therapeutics, Inc. is a biotechnology company. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
| JIYA ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer | |
| Hemmo Pharma LLP | Director/Board Member | ||
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
| Okarios AG | Chief Operating Officer | ||
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Director/Board Member | |
| TEMPEST THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 40 |
| Switzerland | 5 |
| France | 4 |
| United Kingdom | 3 |
| India | 3 |
Sectoral
| Health Technology | 40 |
| Consumer Services | 6 |
| Finance | 3 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 50 |
| Corporate Officer/Principal | 48 |
| Director of Finance/CFO | 28 |
| Chief Tech/Sci/R&D Officer | 26 |
| Independent Dir/Board Member | 20 |
Most connected contacts
| Insiders | |
|---|---|
| Thomas Woiwode | 39 |
| Rekha Hemrajani | 17 |
| Linda Rubinstein | 16 |
| Eric Carter | 15 |
| Leone Patterson | 14 |
| Richard Beckman | 12 |
| Jack Anthony Thrift | 11 |
| Rabia Ozden | 9 |
| Julie Clark | 9 |
| John Rakow | 8 |
| Mehdi Gasmi | 8 |
| Soo Hong | 8 |
| Angela Thedinga | 7 |
| Star Seyedkazemi | 7 |
| Nancy E. Pecota | 6 |
- Stock Market
- Insiders
- Jim Wang
- Company connections
